Conn. Gen. Stat. § 4a-53d: Advisory Council on Pharmaceutical Procurement. Membership. Conflict prohibition. Reports.

(a) There is established an Advisory Council on Pharmaceutical Procurement to advise the Commissioner of Administrative Services and drug purchasing agencies on prescription drug negotiations pursuant to sections 4a-53b and 4a-53c.

(b) The council shall consist of five members appointed by the Governor, one of which shall be designated by the Governor to serve as chairperson of the council. The council shall include members who have expertise in health policy, health care economics or clinical medicine.

(c) All initial appointments to the council shall be made not later than thirty days after October 1, 2025. Any vacancy shall be filled by the appointing authority.

(d) The chairperson shall schedule the first meeting of the council, which shall be held not later than sixty days after October 1, 2025.

(e) No member of the council may (1) have a direct ownership or investment interest in a pharmaceutical company, (2) be employed by such company or participate in the management of such company, or (3) receive or have the right to receive, directly or indirectly, remuneration under a compensation arrangement with such company.

(f) Not later than January 1, 2026, and annually thereafter, the council shall submit a report on its findings and recommendations to the Commissioner of Administrative Services and the joint standing committees of the General Assembly having cognizance of matters relating to general law, human services and public health, in accordance with the provisions of section 11-4a.